Free Access
Issue
J Extra Corpor Technol
Volume 41, Number 2, June 2009
Page(s) 73 - 78
DOI https://doi.org/10.1051/ject/200941073
Published online 15 June 2009
  1. Hill JG, O’Brien TG, Murray JJ, et al. Extracorporeal oxygen for acute post-traumatic respiratory failure (shock lung syndrome): Use of the Bramson membrane lung. N Engl J Med. 1972;286:629. [CrossRef] [PubMed] [Google Scholar]
  2. Bartlett RH, Gazzaniga AB, Jefferies MR, et al. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs. 1976;22:80–93. [PubMed] [Google Scholar]
  3. Bartlett RH. Extracorporeal oxygenation in infants. Hosp Pract. 1984;19:139–51. [CrossRef] [Google Scholar]
  4. Bartlett RH, Gazzaniga AB, Toomasian J, et al. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure: 100 cases. Ann Surg. 1986;40:519–27. [Google Scholar]
  5. Wolfson PJ. The development and use of extracorporeal membrane oxygenation in neonates. Ann Thorac Surg. 2003;76:S2224–9. [CrossRef] [Google Scholar]
  6. Duncan BW, Hraska V, Jonas RA, et al. Mechanical circulatory support for pediatric cardiac patients, Circulation. 1996;94(Suppl):I173. [Google Scholar]
  7. Duncan BW, Ibrahim AE, Hraska V, et al. Use of rapid-deployment extracorporeal membrane oxygenation for the resuscitation of pediatric patients with heart disease after cardiac arrest. J Thorac Cardiovasc Surg. 1998;116:305–11. [CrossRef] [Google Scholar]
  8. Abderson HL, Delius RE, Sinard JM, et al. Early experience with adult extracorporeal membrane oxygenation in the modern era. Ann Thorac Surg. 1992;53:553–63. [CrossRef] [Google Scholar]
  9. Anderson HL, Steimle C, Sharpiro MB, et al. Extracorporeal life support for adult cardiorespiratory failure. Surgery. 1993;114:161–73. [PubMed] [Google Scholar]
  10. Allison P, Kurusz M, Graves D, et al. Devices and monitoring during neonatal ECMO: Survey results. Perfusion. 1990;5:193–201. [CrossRef] [PubMed] [Google Scholar]
  11. Lawson DS, Walczak R, Lawson AF, et al. North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results. J Extra Corpor Technol. 2004;36:16–21. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Agati A, Mignosa C, Ciccarello G, Dario A, Undar A. Pulsatile ECMO in neonates and infants: First European clinical experience with a new device. ASAIO J. 2005;51:508–12. [CrossRef] [PubMed] [Google Scholar]
  13. Searles B, Gunst G, Terry B, et al. 2004 survey of ECMO in the neonate after open heart surgery: Circuitry and team roles. J Extra Corpor Technol. 2005;37:351–4. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Horton S, Thuys C, Bennett M, Augustin S, Rosenberg M, Brizard C. Experience with the Jostra Rotaflow and Quadrox D oxygenator for ECLS. Perfusion. 2004;19:17–23. [CrossRef] [PubMed] [Google Scholar]
  15. Khoshbin E, Westrope C, Pooboni S, et al. Performance of poly methyl pentene oxygenators for neonatal extracorporeal membrane oxygenation: a comparison with silicone membrane oxygenators. Perfusion. 2005;20:129–34. [CrossRef] [PubMed] [Google Scholar]
  16. Lappegard KT, Fung M, Bergseth G, et al. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation. Ann Thorac Surg. 2004;77:932–41. [CrossRef] [Google Scholar]
  17. Moen O, Hogasen K, Fosse E, et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1997;63:105–11. [CrossRef] [Google Scholar]
  18. Izuha H, Hattori M, Igari T, Wakamatsu D, Watanabe M, Yokoyama H. Changes in platelet aggregation during cardiopulmonary bypass: Comparison of poly-2-methoxyethylacrylate and heparin as a circuit coating material. J Artif Organs. 2005;8:41–6. [CrossRef] [PubMed] [Google Scholar]
  19. Meinhardt JP, Annich GM, Miskulin J, et al. Thrombogenicity is not reduced when heparin and phsopholipid bonded circuits are used in a rabbit model of extracorporeal circulation. ASAIO J. 2003;49:395–400. [Google Scholar]
  20. Tayama E, Hayashida N, Akasu K. Biocompatibility of heparin-coated extracorporeal bypass circuits: New heparin bonded bioline system. J Artif Organs. 2000;24:618–23. [CrossRef] [Google Scholar]
  21. Ikuta T, Fujii H, Shibata T, et al. A new poly-2-methoxyethylacrylatecoated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. Ann Thorac Surg. 2004;77:1678–83. [CrossRef] [Google Scholar]
  22. Ota K, Tatsumi E, Taenaka Y, et al. Prolonged heparinless animal testing of a newly developed antithrombogenic heparin-coated pediatric ECMO system. Pulmonary abstracts. ASAIO J. 2005;51:48a. [Google Scholar]
  23. Koster A, Sanger S, Hansen R, et al. Prevalence and persistence of heparin/platelet factor IV antibodies in patients with heparin coating and non-coated ventricular assist devices. ASAIO J. 2000;46:319–22. [CrossRef] [PubMed] [Google Scholar]
  24. Yamakasi Y, Hayashi T, Yotsuida H, et al. Early experience with low-prime (99ml) extra corporeal membrane oxygenation support in children. ASAIO J. 2006;52:110–4. [CrossRef] [PubMed] [Google Scholar]
  25. Ambrose TM, Parvin CA, Mendeloff E, Luchtman-Jones L. Evaluation of the TAS analyzer and the low-range heparin management test in patients undergoing extracorporeal membrane oxygenation. Clin Chem. 2001;47:858–66. [CrossRef] [PubMed] [Google Scholar]
  26. Owings JT, Pollock ME, Gosselin RC, et al. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques. Arch Surg. 2000;135:1042–7. [CrossRef] [Google Scholar]
  27. Codispoti M, Ludlam CA, Simpson D, Mankad PS. Individualized heparin and protamine administration in infants and children undergoing cardiac operations. Ann Thorac Surg. 2001;71:922–8. [CrossRef] [Google Scholar]
  28. Baird C, Gabdhi D, Zurakowski D, et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose. Presented at the 42nd Annual Meeting of the Society of Thoracic Surgeons, Chicago, IL, January 30 to February 1, 2006. [Google Scholar]
  29. Bull BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during extracorporeal circulation: II The use of a dose response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685–9. [CrossRef] [Google Scholar]
  30. Cheung AT, Levin SK, Weiss SJ, et al. Intracardiac thrombus:A risk of incomplete anticoagulation for cardiac operations. Ann Thorac Surg. 1994;58:541–2. [CrossRef] [Google Scholar]
  31. Despotis GJ, Joist JH, Hogue CW, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1995;110:46–54. [CrossRef] [Google Scholar]
  32. Jaggers JJ, Neal MC, Smith PK, Ungerleider RM, Lawson JH. Infant cardiopulmonary bypass: A procoagulant state. Ann Thorac Surg. 1999;68:513–20. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.